Antibodies to citrullinated peptides and risk of coronary heart disease

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 243-246

  Cambridge, Geraldine ^a   Acharya, Jayshree ^a   Cooper, Jackie A ^a   Edwards, Jonathan C ^a   Humphries, Steve E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autoantibodies; CCP; Citrullination; Coronary artery disease

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ANTIBODY BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERUM; SMOKING;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CORONARY ARTERY DISEASE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; VASCULITIS;

EID: 84876782375     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.009     Document Type: Article

References (16)

1. Hingorani A.D., Casas J.P. The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet 2012, 379(9822):1214-1224.
2. Sarwar N., Butterworth A.S., Freitag D.F., et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012, 379(9822):1205-1213.
3. Chung C.P., Avalos I., Raggi P., Stein C.M. Atherosclerosis and inflammation: insights from rheumatoid arthritis. Clin Rheumatol 2007, 26:1228-1233.
4. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
5. Gyorgy B., Tóth E., Tarcsa E., Falus A., Buzás E.I. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 2006, 38:1662-1677.
6. van Venrooij W.J., van Beers J.J., Pruijn G.J. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 2008, 1143:268-285.
7. Nielen M.M., van Schaardenburg D., Reesink H.W., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
8. Sebbag M., Chapuy-Regaud S., Auger I., et al. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Jt Bone Spine 2004, 71:493-502.
9. El-Barbary A.M., Kassem E.M., El-Sergany M.A., Essa S.A., Eltomey M.A. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J Rheumatol 2011, 38:828-834.
10. Cooper J.A., Miller G.J., Humphries S.E. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis 2005, 181:93-100.
11. Miller G.J., Bauer K.A., Barzegar S., Cooper J.A., Rosenberg R.D. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996, 75:767-771.
12. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-12.
13. Wiles N., Symmons D.P., Harrison B., et al. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target?. Arthritis Rheum 1999, 42:1339-1346.
14. Beniac D.R., Wood D.D., Palaniyar N., Ottensmeyer F.P., Moscarello M.A., Harauz G. Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J Struct Biol 2000, 129:80-95.
15. Klareskog L., Malmström V., Lundberg K., Padyukov L., Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011, 23:92-98.
16. Berek C., Kim H.J. B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol 1997, 9:261-268.